Evidence map›Paper›PMID 35723757›Full record

ReviewArchives of virology2022

COVID-19 exit strategy during vaccine implementation: a balance between social distancing and herd immunity.

Suhad Daher-Nashif, Rania Al-Anany, Menatalla Ali, Khadija Erradi, Elmoubasher Farag, Abdallah M Abdallah, Mohamed M Emara

Open access · hybridAbstract readReview
In one paragraph

Review in Archives of virology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Suhad Daher-NashifPopulation Medicine Department, College of Medicine, QU Health, Qatar University, Doha, Qatar.
Rania Al-AnanyBasic Medical Sciences Department, College of Medicine, QU Health, Qatar University, Doha, Qatar.
Menatalla AliBasic Medical Sciences Department, College of Medicine, QU Health, Qatar University, Doha, Qatar.
Khadija ErradiBasic Medical Sciences Department, College of Medicine, QU Health, Qatar University, Doha, Qatar.
Elmoubasher FaragPublic Health Department, Health Protection and Communicable Diseases, Ministry of Public Health, Doha, Qatar.
Abdallah M AbdallahBasic Medical Sciences Department, College of Medicine, QU Health, Qatar University, Doha, Qatar.
Mohamed M EmaraBasic Medical Sciences Department, College of Medicine, QU Health, Qatar University, Doha, Qatar. memara@qu.edu.qa.ORCID http://orcid.org/0000-0002-0921-6313
Qatar University · QAMinistry of Public Health · QA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Currently, health authorities around the world are struggling to limit the spread of COVID-19. Since the beginning of the pandemic, social distancing has been the most important strategy used by most countries to control disease spread by flattening and elongating the epidemic curve. Another strategy, herd immunity, was also applied by some countries through relaxed control measures that allow the free spread of natural infection to build up solid immunity within the population. In 2021, COVID-19 vaccination was introduced with tremendous effort as a promising strategy for limiting the spread of disease. Therefore, in this review, we present the current knowledge about social distancing, herd immunity strategies, and aspects of their implementation to control the COVID-19 pandemic in the presence of the newly developed vaccines. Finally, we suggest a short-term option for controlling the pandemic during vaccine application.

Indexed as

COVID-19COVID-19 VaccinesHumansImmunity, HerdPandemicsPhysical DistancingSARS-CoV-2COVID-19 Vaccines

Identifiers

PMID35723757
PMCPMC9208258
OpenAlexW4283162572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.